How does COVID-19 kill? The immunobiology of SARS-CoV-2
The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in ~850,000 confirmed cases of coronavirus disease 2019 (COVID-19) illness and nearly 47,000 deaths. While the majority of cases are mild to moderate, ~15% of COVID-19 cases result in severe disease including acute respiratory distress syndrome, cytokine release syndrome, and potentially death. But there is much uncertainty as to why some patients progress to severe COVID-19 illness and others do not. Join our I4Q seminar on Thursday, April 30th at noon for a discussion with Stephanie Langel on the immunobiology of SARS-CoV-2 and how the immune response plays a role in COVID-19 mortality.
For the Zoom meeting information please email Richard Barfield.